Effectiveness and Safety of Exercise Therapy for Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Chronic kidney disease (CKD) represents a significant global public health concern, impairing patients' quality of life, functional status, and increases overall morbidity and mortality. Although exercise therapy has demonstrated potential benefits for the management of non-dialysis-dependent CKD (NDD-CKD), the evidence base remains to be consolidated. Therefore, this review aims to evaluate the effectiveness and the safety of exercise intervention on NDD-CKD patients by integrating the available high-quality studies. Methods A systematic literature search was conducted using PubMed and Ichushi-Web, a database of Japanese medical literature, up to February 29, 2024. We pooled only randomized controlled trials (RCTs) comparing exercise intervention with usual care, and conducted meta-analyses based on a random effects inverse variance model. Results A systematic literature search identified 9131 articles, and after screening, 19 RCTs were included for qualitative evaluation. We included 15 RCTs in the quantitative meta-analysis. No RCTs investigated the effects of exercise on all-cause mortality or hospitalization. The meta-analysis of kidney function, including the estimated glomerular filtration rate using serum creatinine (eGFRcr) and the degree of albuminuria/proteinuria showed no significant difference between the intervention and control groups. However, a pooled analysis on eGFRcr suggested an attenuated decline in the intervention group (mean difference: 0.96 mL/min/1.73 m 2 ; 95% CI, − 1.25 to 3.17). In addition, exercise intervention led to significant improvements in several secondary outcomes: exercise capacity (VO 2 peak increased by 2.13 mL/kg/min), ambulatory function (6-minute walk distance increased by 51.16 m), and Health-Related Quality of Life (HR-QoL) (significant improvements across multiple subscales of KDQOL, as well as SF-12/36 Physical and Mental Component Summaries). No significant increase in the incidence of adverse events, such as musculoskeletal injuries, was observed in the intervention groups. Conclusions Exercise therapy is a safe and effective strategy for improving exercise capacity, ambulatory function, and HR-QoL in patients with NDD-CKD. These findings support its incorporation into routine clinical care.

Article activity feed